Clicdevice

Fresenius Medical Care North America (FMCNA), a division of Fresenius Renal Therapies has unveiled the CLiC device, the latest technological developments of their Crit-Line technology product line to support hemodialysis treatment.

The CLiC device is instrumental during a hemodialysis (HD) treatment, where it non-invasively measures hematocrit, oxygen saturation and percent change in intravascular blood volume.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

It is integrated into the 2008T hemodialysis machine and offers immediate, real-time access to a patient’s hematocrit, percent change in blood volume and oxygen saturation data, as well as essential dialysis treatment information required to shape the intradialytic procedure.

Fluid overload is a common and serious problem that creates severe complications in dialysis patients and is a major cause of reported hospitalisations.

The CLiC device is designed to enable the health care professional to remove the maximum amount of fluid from the hemodialysis patient while preventing the common symptoms of dialysis such as nausea, cramping and vomiting.

“The CLiC device represents a significant step forward in the evolution of volume management.”

FMCNA chief medical officer Frank Maddux said: “The CLiC device represents a significant step forward in the evolution of volume management.

“By assisting clinical staff in managing hemodialysis patients’ complex fluid and intravascular volume conditions, the CLiC will be a valuable tool for clinicians.

“Moreover, with the integration of the CLiC device into the 2008T machine, clinical staff can more quickly recognise a patient’s risk for low-blood pressure during hemodialysis resulting from certain ultrafiltration and intravascular blood volume characteristics.

“Once the CLiC device alerts staff, they can pause ultrafiltration until the clinicians can assess the situation of their patient.”

Image: An image of a hemodialysis unit’s dialysate solution tanks. Photo: courtesy of BillpSea.